Metraipolis › archive › dc_96d648d6879e

Identification of biomarkers of Shenhailong formula in benign prostatic hyperplasia treatment: An observation study using network pharmacology and Mendelian… — Europe PMC PMID:41305716

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41305716
DOI
10.1097/md.0000000000045619
License (as archived)
solo-consultazione
Archived
2026-11-08T20:32:01.218Z
SHA-256 of the archived text
93e0da99086b13d9c5c5db13de80a17a742b8ecd0edbdc4bb21381c2f7577c27
Stable URL of this page
https://metraipolis.com/documento/dc_96d648d6879e

How to cite

Identification of biomarkers of Shenhailong formula in benign prostatic hyperplasia treatment: An observation study using network pharmacology and Mendelian… — Europe PMC PMID:41305716 — Europe PMC (en), https://europepmc.org/article/MED/41305716 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_96d648d6879e (Metraipolis archive dc_96d648d6879e, sha256 93e0da99086b13d9c5c5db13de80a17a742b8ecd0edbdc4bb21381c2f7577c27)
BibTeX
@misc{dc96d648d6879e,
  title = {Identification of biomarkers of Shenhailong formula in benign prostatic hyperplasia treatment: An observation study using network pharmacology and Mendelian… — Europe PMC PMID:41305716},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41305716},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_96d648d6879e; sha256 93e0da99086b13d9c5c5db13de80a17a742b8ecd0edbdc4bb21381c2f7577c27},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41305716. Agents can read the archived copy with the MCP tool read_document.